ANIK R&D Expense Growth
Anika Therapeutics Inc · R&D Expense Growth
ANIK R&D Expense Growth
Latest reported0.88%period ending
ANIK FY R&D Growth (YoY) (0.00% → 0.88%)
Latest values, visible window
High-resolution chart · PNG
ANIK r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0.8847% | |
| 17.3735% | |
| 18.7872% | |
| -32.9564% | |
| 16.6275% | |
| 40.6001% | |
| -8.3837% | |
| -3.1777% | |
| 75.0559% | |
| 19.4169% | |
| 10.3491% | |
| 15.3583% | |
| 31.0287% | |
| -12.6586% | |
| -10.2652% | |
| -15.9738% | |
| 10.5755% | |
| 69.5233% | |
| 20.6885% | |
| -23.5588% | |
| 15.7573% | |
| 57.4952% | |
| -33.9313% | |
| -8.2418% | |
| 31.3049% | |
| -22.3813% | |
| 110% | |
| 0% | |
| 0% | |
| -100% | |
| -13.3333% | |
| 0% | |
| 0% |